UTI Stock Forecast & Price Target

Universal Technical is supported by strong underlying demand that continues to outpace graduate supply, with UTI and Concorde both benefiting from skilled-trades shortages, healthcare demand, and employer partnerships such as Heartland Dental. Recent campus launches in Atlanta and San Antonio are tracking ahead of plan, while FY/26 results showed revenue of $221.4 million in the second quarter, 6.7% growth, and new student starts up 14.5% to 4,110, signaling resilient enrollment momentum. Although near-term margins are pressured by heavy investment, management’s FY/26 guidance and longer-term plans for new campuses and programs suggest meaningful operating leverage, revenue expansion, and stronger profitability as the build-out matures.

Universal Technical is facing a weaker fundamental setup because High School starts in the September quarter are running roughly 1,000 below plan, driven by recruiter turnover, lower productivity, and poor lead follow-up despite leads rising 15%. Management has already cut full-year revenue guidance to $893 million-$900 million from $905 million-$915 million and Adjusted EBITDA to $100 million-$103 million from $114 million-$119 million, while free cash flow guidance fell to breakeven to negative $20 million as CapEx rises. Although Q2/26 revenue grew 6.7% to $221.4 million and new student starts rose 13.8% to 7,569, operating expenses climbed 16.0% and Adjusted EBITDA fell 51.0%, underscoring margin pressure from growth investments and a high fixed-cost model.